Global CAR-T Therapy Global Market Report 2024

CAR-T Therapy Global Market Report 2024 – By Type (Monotherapy, Combination Therapy), By Target Antigen (CD19, CD22, BCMA, Other Target Antigens), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : 175 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
Customise Your Report
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying
CAR-T Therapy Market

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

CAR-T Therapy Market Definition And Segments

The chimeric antigen receptor-T therapy is a type of immunotherapy in which T-cells are taken from the patient’s blood are modified in a laboratory with the addition of a special protein receptor that grants T-cells the power to recognize as well as kill cancer cells easily, along with infusing the same back into that patient. This special protein receptor, known as the chimeric antigen receptor (CAR), attaches to a specific protein in a patient’s cancer cells. The infused cells multiply and prevail in the patient’s body as living drugs.

The main types of chimeric antigen receptor -T therapy is monotherapy and combination therapy. Monotherapy is used in the treatment of any disease with a single drug. The target antigens involved are CD19, CD22, and others that are used in various applications such as acute lymphoblastic leukemia, diffuse large B-cell lymphoma, follicular lymphoma, chronic lymphocytic leukemia, multiple myeloma, and others.

The CAR-T Therapy market covered in this report is segmented –

1) By Type: Monotherapy, Combination Therapy

2) By Target Antigen: CD19, CD22, BCMA, Other Target Antigens

3) By Application: Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Other Applications

The CAR-T Therapy market size has grown rapidly in recent years. It will grow from $2.15 billion in 2023 to $2.55 billion in 2024 at a compound annual growth rate (CAGR) of 19.1%. The growth in the historic period can be attributed to increases in healthcare expenditure, increases in pharmaceutical R&D expenditure, and advances in drug discovery.

The CAR-T Therapy market size is expected to see rapid growth in the next few years. It will grow to $4.74 billion in 2028 at a compound annual growth rate (CAGR) of 16.7%. The growth in the forecast period can be attributed to an increase in blood cancer incidence rate, rise in healthcare expenditure, strong pipeline of drugs, and rising focus on CAR-T therapy. Major trends in the forecast period include investing in the R&D for creating remodeled CAR-T therapy to avoid neurological side effects, creating off-the-shelf allogeneic CAR-T therapy for advanced cancer treatment, manufacturing next-generation CAR T cells for improved treatment of high-grade glioma, investing in ai and machine learning solutions to optimize future CAR-T therapy, carrying out strategic collaborations to boost innovations, collaborating or acquiring competitor companies to expand CAR-T therapy portfolio, and investing in the CAR-T therapy to make it more effective.

Financial Support Driving Growth In The CAR-T Therapy Market

The CAR-T therapy market is driven by the increasing financial support provided by different organizations to promote the development and consumption of CAR-T therapy. The government and non-government organizations provide financial support to the companies in the CAR-T therapy market for research and development and the patients for their treatment of acute lymphoblastic leukemia (ALL). For instance, in December 2021, the University of California San Diego School of Medicine (CA, USA) was granted funding of $ 4.1 million for the development of novel chimeric antigen receptor (CAR-T) cell therapy. The grant was awarded by the California Institute for Regenerative Medicine (CIRM; CA, USA) governing board. The financial support provided by different organizations towards CAR-T therapy positively drives the growth of the CAR-T therapy market.

Increasing Cancer Prevalence Driving Growth In The CAR-T Therapy Market

The rising prevalence of cancer is expected to propel the growth of the CAR-T therapy market going forward. The rising prevalence of cancer refers to the increasing number of diagnosed cases of cancer within a specific population or region over a given period. The rising prevalence of cancer has driven research and investment in cancer therapies, including cellular immunotherapies. These treatments represent a significant advancement in the field of oncology and are particularly relevant for addressing the needs of cancer patients. For instance, in 2021, the American Cancer Society journal, estimated numbers of new cancer cases and deaths in 2021 (In 2021, there will likely be 608,570 cancer deaths in the United States and 1.9 million new cases of cancer diagnosed). Therefore, the rising prevalence of cancer is driving the growth of the CAR-T therapy market.

Major companies operating in the CAR-T Therapy market report are Gilead Sciences, Novartis AG, Biocon, Gracell Biotechnology Ltd., Aeon Therapeutics, CARsgen Therapeutics, Daiichi Sankyo, Otsuka Pharmaceutical, Ono Pharmaceutical, Japan Tissue Engineering, Nipro Corporation, Takeda Pharmaceutical Company, Astellas Pharma, Innovative Cellular Therapeutics, Cellular Biomedicine Group, PersonGen Biomedicine, Hebei Senlang Biotech, Adaptimmune(UK), Autolus Therapeutics, BioNTech, Cellectis, Celyad, Crescendo Biologics, GammaDelta Therapeutics, Immatics, Biocad, Celgene Corporation, Johnson & Johnson, F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Amgen, AstraZeneca, Bayer AG, Merck, Pfizer, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio Amgen, Regen BioPharma, OncoSec Medical Incorporated, Precision BioSciences, Bellicum, Sandoz AG, GlaxoSmithKline PLC, Elekta, SudairPharma, Janssen, Aspen, Adcock Ingram

Limitations On CAR-T Therapy Hindering Market Growth

The limitations on the application of CAR-T therapy limit the growth of the market. The limitations of CAR-T therapy include its failure to treat other types of cancer, side effects, and the high cost of treatment. CAR-T therapy is widely used as a treatment for a particular type of blood cancer and fails to treat other types of cancers such as lung cancer or breast cancer. Further, in many cases, the application of CAR-T therapy results in cytokine release syndrome (CRS). CRS is a severe flu-like condition causing high fever, nausea, chills, headache, rash, and troubled breathing. Further, the high cost limits the growth of the market. According to a report from Kaiser Health News, the per-patient cost of CAR-T cell therapy was more than $1 million in 2021. Thus, the growth of CAR-T therapy is restricted by the various limitations on the application of CAR-T therapy.

Clinical Trials And Advancements In CAR-T Therapy For Multiple Myeloma

The companies in the CAR-T therapy market are conducting clinical trials to assess the ability of CAR-T therapy to treat multiple myeloma. Multiple myeloma is a type of white blood cell cancer where the cancer cells accumulate in the bone marrow and surround the healthy blood cells. CAR-T therapy is being tested as a treatment for multiple myeloma. CAR-T cells are modified to target the multiple myeloma-causing cells to treat the relapsed or refractory multiple myeloma (RRMM). For instance, in December 2021, Novartis announced the introduction of T-Charge, the company’s next-generation CAR-T platform that will serve as the foundation for various new investigational CAR-T cell therapies in the Novartis pipeline. The product was in the early clinical stage (Phase I).

Innovation In CAR-T Therapy Market: Introduction Of BioCentriq By Terumo Blood And Cell Technologies

Major companies operating in the CAR-T cell therapies market are innovating new products such as BioCentriq to increase their profitability in the market. BioCentriq serves as a valuable resource for organizations involved in the development, manufacturing, and research of cell and gene therapies, facilitating advancements in the field and ultimately improving patient care. For instance, in October 2023, Terumo Blood and Cell Technologies, a Japan-based medical technology company, launched BioCentriq to generate public CAR-T cell data using Terumo BCT’s CGT manufacturing platforms, In collaboration with Terumo BCT, BioCentriq aims to pioneer publicly accessible data on rapid CAR-T cell manufacturing using the Quantum Flex and Finia platforms. This innovative trial seeks to showcase the efficient production of high-quality CAR-T cells, leveraging the seamless integration of Terumo BCT's technology and BioCentriq's process expertise for streamlined, GMP-translatable workflows.

Astellas' Strategic Acquisition Of Iveric Bio Expanding Ocular Healthcare Capabilities

In July 2023, Astellas Pharma Inc., a Japan-based pharmaceutical company, acquired Iveric Bio for $5.9 billion. With this acquisition, Astellas is better positioned to serve patients with ocular illnesses at high risk of going blind. The chance to establish a top-tier organization with Iveric Bio's ophthalmology knowledge and capabilities and Astellas' global resources is exceptional and has the potential to help patients worldwide who suffer from blinding retinal illnesses, including GA. The transaction was subject to Iveric Bio's stockholders' approval and other usual closing requirements, such as obtaining necessary regulatory approvals. Iveric Bio is a US-based Biotech company.

North America was the largest region in the CAR-T therapy market in 2023. Western Europe was the second-largest region in the global CAR-T therapy market share. The regions covered in the CAR-T Therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the CAR-T Therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The chimeric antigen receptor -T therapy market includes revenues earned by CAR-T therapy products and related services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The chimeric antigen receptor -T therapy market research report is one of a series of new reports from The Business Research Company that provides chimeric antigen receptor -T therapy market statistics, including chimeric antigen receptor -T therapy industry global market size, regional shares, competitors with a chimeric antigen receptor -T therapy market share, detailed chimeric antigen receptor -T therapy market segments, market trends and opportunities, and any further data you may need to thrive in the chimeric antigen receptor -T therapy industry. This chimeric antigen receptor -T therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

CAR-T Therapy Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $2.55 billion
Revenue Forecast In 2033 $4.74 billion
Growth Rate CAGR of 16.7% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type: Monotherapy, Combination Therapy
2) By Target Antigen: CD19, CD22, BCMA, Other Target Antigens
3) By Application: Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Other Applications
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Gilead Sciences; Novartis AG; Biocon; Gracell Biotechnology Ltd; Aeon Therapeutics; CARsgen Therapeutics; Daiichi Sankyo; Otsuka Pharmaceutical; Ono Pharmaceutical; Japan Tissue Engineering; Nipro Corporation; Takeda Pharmaceutical Company; Astellas Pharma; Innovative Cellular Therapeutics; Cellular Biomedicine Group; PersonGen Biomedicine; Hebei Senlang Biotech; Adaptimmune(UK); Autolus Therapeutics; BioNTech; Cellectis; Celyad; Crescendo Biologics; GammaDelta Therapeutics; Immatics; Biocad; Celgene Corporation; Johnson & Johnson; F. Hoffmann-La Roche Ltd; Eli Lilly and Company; Amgen; AstraZeneca; Bayer AG; Merck; Pfizer; Juno Therapeutics; Allogene Therapeutics; Bluebird Bio Amgen; Regen BioPharma; OncoSec Medical Incorporated; Precision BioSciences; Bellicum; Sandoz AG; GlaxoSmithKline plc; Elekta; SudairPharma; Janssen; Aspen; Adcock Ingram
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. CAR-T Therapy Market Characteristics

    3. CAR-T Therapy Market Trends And Strategies

    4. CAR-T Therapy Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global CAR-T Therapy Market Size and Growth

    5.1. Global CAR-T Therapy Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global CAR-T Therapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global CAR-T Therapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. CAR-T Therapy Market Segmentation

    6.1. Global CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Monotherapy

    Combination Therapy

    6.2. Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    CD19

    CD22

    Other Target Antigens

    6.3. Global CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Acute Lymphoblastic Leukemia

    Diffuse Large B-Cell Lymphoma

    Follicular Lymphoma

    Chronic Lymphocytic Leukemia

    Multiple Myeloma

    Other Applications

    7. CAR-T Therapy Market Regional And Country Analysis

    7.1. Global CAR-T Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global CAR-T Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific CAR-T Therapy Market

    8.1. Asia-Pacific CAR-T Therapy Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China CAR-T Therapy Market

    9.1. China CAR-T Therapy Market Overview

    9.2. China CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India CAR-T Therapy Market

    10.1. India CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan CAR-T Therapy Market

    11.1. Japan CAR-T Therapy Market Overview

    11.2. Japan CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia CAR-T Therapy Market

    12.1. Australia CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia CAR-T Therapy Market

    13.1. Indonesia CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea CAR-T Therapy Market

    14.1. South Korea CAR-T Therapy Market Overview

    14.2. South Korea CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe CAR-T Therapy Market

    15.1. Western Europe CAR-T Therapy Market Overview

    15.2. Western Europe CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK CAR-T Therapy Market

    16.1. UK CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany CAR-T Therapy Market

    17.1. Germany CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France CAR-T Therapy Market

    18.1. France CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy CAR-T Therapy Market

    19.1. Italy CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain CAR-T Therapy Market

    20.1. Spain CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe CAR-T Therapy Market

    21.1. Eastern Europe CAR-T Therapy Market Overview

    21.2. Eastern Europe CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia CAR-T Therapy Market

    22.1. Russia CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America CAR-T Therapy Market

    23.1. North America CAR-T Therapy Market Overview

    23.2. North America CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA CAR-T Therapy Market

    24.1. USA CAR-T Therapy Market Overview

    24.2. USA CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada CAR-T Therapy Market

    25.1. Canada CAR-T Therapy Market Overview

    25.2. Canada CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America CAR-T Therapy Market

    26.1. South America CAR-T Therapy Market Overview

    26.2. South America CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil CAR-T Therapy Market

    27.1. Brazil CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East CAR-T Therapy Market

    28.1. Middle East CAR-T Therapy Market Overview

    28.2. Middle East CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa CAR-T Therapy Market

    29.1. Africa CAR-T Therapy Market Overview

    29.2. Africa CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. CAR-T Therapy Market Competitive Landscape And Company Profiles

    30.1. CAR-T Therapy Market Competitive Landscape

    30.2. CAR-T Therapy Market Company Profiles

    30.2.1. Gilead Sciences

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Novartis AG

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Biocon

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Gracell Biotechnology Ltd

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Aeon Therapeutics

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. CAR-T Therapy Market Other Major And Innovative Companies

    31.1. CARsgen Therapeutics

    31.2. Daiichi Sankyo

    31.3. Otsuka Pharmaceutical

    31.4. Ono Pharmaceutical

    31.5. Japan Tissue Engineering

    31.6. Nipro Corporation

    31.7. Takeda Pharmaceutical Company

    31.8. Astellas Pharma

    31.9. Innovative Cellular Therapeutics

    31.10. Cellular Biomedicine Group

    31.11. PersonGen Biomedicine

    31.12. Hebei Senlang Biotech

    31.13. Adaptimmune(UK)

    31.14. Autolus Therapeutics

    31.15. BioNTech

    32. Global CAR-T Therapy Market Competitive Benchmarking

    33. Global CAR-T Therapy Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The CAR-T Therapy Market

    35. CAR-T Therapy Market Future Outlook and Potential Analysis

    35.1 CAR-T Therapy Market In 2028 - Countries Offering Most New Opportunities

    35.2 CAR-T Therapy Market In 2028 - Segments Offering Most New Opportunities

    35.3 CAR-T Therapy Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global CAR-T Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global CAR-T Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Gilead Sciences Financial Performance
  • Table 75: Novartis AG Financial Performance
  • Table 76: Biocon Financial Performance
  • Table 77: Gracell Biotechnology Ltd Financial Performance
  • Table 78: Aeon Therapeutics Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global CAR-T Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global CAR-T Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Gilead Sciences Financial Performance
  • Figure 75: Novartis AG Financial Performance
  • Figure 76: Biocon Financial Performance
  • Figure 77: Gracell Biotechnology Ltd Financial Performance
  • Figure 78: Aeon Therapeutics Financial Performance
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
Read More
Global Gene Therapy Market 2022 – Market Opportunities And Strategies
Read More
The Microbiome Market Share, Market Size, And Growth Rate 2022
Read More
Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
Read More
Electrophysiology Devices And Equipment Global Market Report 2024 – By Product Type (Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Lab Systems), By Monitoring Device Type (Electrocardiograph (ECG), Electroencephalograph (EEG), Electrocorticograph (ECoG), Electromyograph (EMG), Electroretinograph (ERG), Electrooculograph (EOG), Holter Monitoring Devices, X-Ray Systems, Imaging and 3D Mapping Systems, Diagnostic Electrophysiology Catheters, By Indication Analysis (Atrioventricular Nodal Reentry Tachycardia (AVNRT), Wolff-Parkinson-White Syndrome (WPW), Atrial Flutter, Atrial Fibrillation), By End-Users (Hospitals, Diagnostic centers, Clinics) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Bioinformatics Global Market Report 2024 – By Products and Services (Knowledge Management Tools, Data Analysis Platforms, Services), By Application (Metabolomics, Molecular Phylogenetics, Transcriptomics, Proteomics, Chemoinformatics, Genomics, Other Applications), By End Users (Pharmaceutics, Animal Study, Agriculture, Forensic Science, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Stem Cell/Cord Blood Banking Global Market Report 2024 – By Cell Type (Adult Stem Cells, Umbilical Cord Blood Stem Cells, Embryonic Stem Cells), By Service (Collection, Processing, Analysis, Storage), By Bank Type (Public, Private), By Application (Leukemia, Anemia, Thalassemia, Autism, Cerebral Palsy, Diabetes, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Analytical Laboratory Instrument Global Market Report 2024 – By Type (Element Analysis, Separation Analysis, Molecular Analysis, Other Types), By Application (Research, Clinical, Diagnostic, Other Applications), By End-User (Hospitals, Diagnostic Laboratories, Pharmaceutical, Biotechnology, Other End-users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Genomics Global Market Report 2024 – By Product Type (Instrument (Including Systems, Service Contract And Software), Reagents (Including Reagents And Consumables)), By Process (Cell Isolation, Sample Preparation, Genomic Analysis), By End User (Academic Institutes, Biopharmaceutical Companies, Clinical Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2024 – By Product (Resectoscopes, Radiofrequency Ablation Device, Urology Lasers, Prostatic Stents, Implants), By Procedure Type (Transurethral Needle Ablation (TUNA), Transurethral Resection Of Prostate (TURP), Transurethral Incision Of Prostate (TUIP), Transurethral Microwave Thermotherapy (TUMT), Laser Surgery, Other Procedure Types), By End-User (Hospitals, Ambulatory Surgical Centres (ASC), Clinics, Home) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Antiemetics And Antinauseants Global Market Report 2024 – By Drug (Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types), By Application (Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types), By End Users (Hospital, Medical Center, Clinic, Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Generic Pharmaceuticals Global Market Report 2024 – By Type (Biosimilars, Generics), By Drug Delivery (Oral, Injectables, Dermal/Topical, Inhaled), By Therapy (CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, Biosimilars, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, And Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033
View Report